about
Current perspectives on HIV-1 antiretroviral drug resistanceIntegrated Microfluidic Nucleic Acid Isolation, Isothermal Amplification, and Amplicon Quantification.A low-cost smartphone-based platform for highly sensitive point-of-care testing with persistent luminescent phosphors.GeneXpert HIV-1 quant assay, a new tool for scale up of viral load monitoring in the success of ART programme in India.Molecular oncology testing in resource-limited settings.HIV in children in a general population sample in East Zimbabwe: prevalence, causes and effectsIon concentration polarization on paper-based microfluidic devices and its application to preconcentrate dilute sample solutions.Access to CD4 Testing for Rural HIV Patients: Findings from a Cohort Study in ZimbabweUsing BD Vacutainer CD4 Stabilization Tubes for Absolute Cluster of Differentiation Type 4 Cell Count Measurement on BD FacsCount and Partec Cyflow Cytometers: A Method Comparison Study from Zimbabwe.The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.Performance Evaluation of the Becton Dickinson FACSPresto™ Near-Patient CD4 Instrument in a Laboratory and Typical Field Clinic Setting in South Africa.Detection of Acute and Early HIV-1 Infections in an HIV Hyper-Endemic Area with Limited Resources.Genetic Variability of HIV-1 for Drug Resistance Assay Development.Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS.Near patient CD4 count in a hospitalized HIV patient population.Point-of-care diagnostics to improve maternal and neonatal health in low-resource settings.Nucleic acid purification from plants, animals and microbes in under 30 seconds.A highly sensitive aptamer-based HIV reverse transcriptase detection assay.Point of Care Diagnostics for HIV in Resource Limited Settings: An Overview
P2860
Q26852626-3D31B240-B245-42AA-A26A-D6F54F0DC73DQ33450601-9E88FC7B-8233-42B2-B0D4-5B1EA52918D3Q33452573-DF88ECCF-286E-4B71-929C-9E18F84A21AAQ33922816-B6F92712-7D6A-46FD-A231-96AE9B8069A4Q34409732-B7DEE9B3-B229-4FC4-92C9-84FD101912B1Q34549966-5C0FEAA1-3617-4FE8-9003-1EE2B109398DQ35107074-D26CE36E-3B25-40E3-9C05-1A7E677F32E1Q35665866-C22810A9-095D-4C33-ADC5-758FC1ACB065Q35752283-AA5EE89E-2177-450B-9AA8-454CB0FB7463Q35850530-1F657B5D-9987-4822-8724-70D4172C4165Q36029182-7B59D81E-34D1-4612-B412-2397B6AEADF3Q36169234-71596AF3-01D3-468A-B908-9D52390FF645Q38745545-A1CE8E9B-47EF-48A3-8E84-D88769611EEFQ38761022-5C70ADBC-2B36-40C6-906A-701AE2FC8262Q41210405-572A053E-8BC3-49CE-9B1B-CCBECD44EE9EQ46303043-5033BFB2-1124-47ED-972C-581D5A261DB8Q47102224-A71A8B33-44DD-4ED9-9188-E5C60BF4BDB7Q52598628-0B8B0F20-2AFE-40E9-B568-5216A767E2AFQ57826025-D87D6F7D-2F5C-4CA4-A9CB-F647AC85113E
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Point of Care Technologies for HIV
@ast
Point of Care Technologies for HIV
@en
type
label
Point of Care Technologies for HIV
@ast
Point of Care Technologies for HIV
@en
prefLabel
Point of Care Technologies for HIV
@ast
Point of Care Technologies for HIV
@en
P2860
P356
P1476
Point of Care Technologies for HIV
@en
P2093
Indira K Hewlett
P2860
P304
P356
10.1155/2014/497046
P577
2014-01-21T00:00:00Z